Pharmacology for the gastrointestinal tract

Area of Science:

• Neonatal pharmacology
• Pediatric drug disposition
• Gastrointestinal drug efficacy

Background:

• Neonatal nurseries commonly use drugs for feeding intolerance, gastroesophageal reflux, and acid-related conditions.
• Existing pharmacokinetic data for these drugs in infants and children is limited, with a particular need for information on preterm infants.

Purpose of the Study:

• To highlight the critical need for further pharmacokinetic and pharmacodynamic data on drugs used in neonatal care.
• To identify the lack of data on proton pump inhibitors (PPIs) in infants, a class likely to be used for refractory acid-related diseases.
• To emphasize the requirement for comprehensive efficacy data for commonly used neonatal drugs.

Main Methods:

• Literature review to identify existing pharmacokinetic and pharmacodynamic data for neonatal drugs.
• Analysis of data gaps, particularly concerning preterm infants and specific drug classes like PPIs.
• Assessment of the need for further clinical studies to characterize drug disposition and efficacy.

Main Results:

• Significant gaps exist in the understanding of drug pharmacokinetics and pharmacodynamics in neonatal populations, especially preterm infants.
• No data is currently available on the disposition of proton pump inhibitors in infants.
• Comprehensive efficacy data for many commonly used neonatal drugs is lacking.

Conclusions:

• Urgent need for research into neonatal drug pharmacokinetics and pharmacodynamics.
• Further studies are essential to guide the safe and effective use of medications in neonates, including PPIs.
• Improved understanding of drug efficacy is critical for managing neonatal gastrointestinal and acid-related disorders.